The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Clinical Research 52

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

Quanticate

OCTOBER 16, 2020

Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time. By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards.

Pharma Companies 52

Pharma Companies FDA International Drugs 52

Vial

DECEMBER 8, 2023

With technological innovation and scientific research propelling the development of new therapies, anticipation for the future is high. Retinitis pigmentosa (RP) UC Irvine researchers have discovered a nanobody that may offer a treatment for retinitis pigmentosa (RP), a degenerative eye disease.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

H1 Blog

JUNE 26, 2024

Worldwide Clinical Trials is a leading full-service global CRO (contract research organization) working with biotech and pharma to create customized solutions. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

PerkinElmer

FEBRUARY 18, 2021

These simple, stable compounds, used to treat various conditions, are the focus for 78% of preclinical research. For the minority of companies working with large molecules and biologics, most said they were in a phase of clinical research. Small molecules are making a comeback.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

Advarra

JUNE 14, 2022

Pre-screening potential participants for a clinical study is common practice at most research sites. What is Pre-Screening in Clinical Research? When time is a precious commodity at a research site, it can be advantageous to delegate the pre-screening process to a non-clinical team member.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Research 52

The Pharma Data

DECEMBER 17, 2020

He previously spent more than a decade at Medtronic in the company ’ s Minimally Invasive Therapies Group where he served as the global vice president and General Manager of General Surgery, and in various roles working on research, development, and strategy. AB2 Bio – Swiss pharma company AB2 Bio Ltd.

Small Molecule 52

Small Molecule Engineering Clinical Development Pharmaceuticals 52

The Anticancer Fund

JUNE 7, 2022

Our intention is to help bring these findings to the attention of the broader cancer research community. All articles need to be critically assessed and viewed in their broader research context. Please get in touch if you’re interested in discussing research based on the findings presented below ( info@anticancerfund.org ).

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. AOP anticipates new opportunities in Austria as a hub for research and business. All jobs have been maintained and the workforce has grown from about 220 to 350.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52